SBSB
IDXX icon

Sullivan, Bruyette, Speros & Blaney’s Idexx Laboratories IDXX Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-617
Closed -$149K – 329
2020
Q1 		$149K Hold
617
– – 0.01% 246
2019
Q4 		$161K Hold
617
– – 0.01% 282
2019
Q3 		$168K Buy
+617
New +$172K 0.01% 263

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's IDXX Position: Q2 2020 in Review

Sullivan, Bruyette, Speros & Blaney sold out of Idexx Laboratories (IDXX) in Q2 2020, closing a stake of 617 shares — an estimated $149K sold.

Sullivan, Bruyette, Speros & Blaney first reported a position in IDXX in Q3 2019 and held it in 3 quarters. The position peaked at $168K in Q3 2019. 802 funds tracked by Wall St. Rank hold IDXX as of Q2 2020.

  • Sullivan, Bruyette, Speros & Blaney reported no remaining Idexx Laboratories position as of Q2 2020 after selling out during the quarter.
  • Sullivan, Bruyette, Speros & Blaney sold 617 Idexx Laboratories shares in Q2 2020, an estimated $149K.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Idexx Laboratories in Q3 2019 and held it in 3 quarters.
  • Sullivan, Bruyette, Speros & Blaney's Idexx Laboratories position peaked at $168K in Q3 2019.
  • 802 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2020.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q2 2020, filed 12 Aug 2020.